Product Information

CLORAZEPATE 15 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.9004 per EA under NDC 13107032101. Its NADAC has been published 234 times since Mar 2, 2022.

FDA first approved this application on Jul 17, 1987. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLORAZEPATE 15 MG TABLET

CLORAZEPATE DIPOTASSIUM
$0.9004per EA
DEA Schedule CIV

Strength

15 mg/1

NDC

13107032101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CLORAZEPATE DIPOTASSIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA071858

FDA Approved

7/17/1987

TE Code

AB

On Market Since

7/17/1987

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for CLORAZEPATE 15 MG TABLET has been published 234 times since Mar 2, 2022, and over the history we have for it it has declined 68.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9004 per EA
All-time high$3.1030 (Jul 13, 2022)
All-time low$0.6724 (Jun 19, 2024)
52-week high$1.7543
52-week low$0.9004
Median price$1.4059
Average price$1.6400
Largest weekly change+94.5% (Mar 20, 2024)
Weeks tracked234
Tracking sinceMar 2, 2022

Price History

1W

-9.6%

1M

-9.6%

3M

-15.2%

6M

-22.1%

1Y

-47.5%

3Y

-24.5%

5Y

N/A

All

-68.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CLORAZEPATE DIPOTASSIUM market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of CLORAZEPATE 15 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CLORAZEPATE 15 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.9004 per EA (NDC 13107032101), effective Aug 19, 2026.

How has the price of CLORAZEPATE 15 MG TABLET changed over time?

Over the history we have for it, the NADAC for CLORAZEPATE 15 MG TABLET has declined 68.5%. It has been tracked across 234 weekly CMS publications since Mar 2, 2022.

What are the highest and lowest recorded NADAC prices for CLORAZEPATE 15 MG TABLET?

Since Mar 2, 2022, the NADAC for CLORAZEPATE 15 MG TABLET has ranged from a low of $0.6724 (Jun 19, 2024) to a high of $3.1030 (Jul 13, 2022), with a median of $1.4059 per EA.

Are there cheaper alternatives to CLORAZEPATE 15 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of CLORAZEPATE 15 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CLORAZEPATE 15 MG TABLET?

CLORAZEPATE 15 MG TABLET (NDC 13107032101) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.